Bausch Health
BHC
#3989
Rank
HK$24.87 B
Marketcap
HK$66.45
Share price
0.59%
Change (1 day)
39.49%
Change (1 year)
Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.

EPS for Bausch Health (BHC)

EPS in 2026 (TTM): -HK$17.76

According to Bausch Health 's latest financial reports the company's current EPS (TTM) is -HK$17.81. In 2025 the company made an earnings per share (EPS) of HK$3.30 an increase over its 2024 EPS that were of -HK$0.94.

EPS history for Bausch Health from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-HK$17.76-639.09%
2025HK$3.30-450%
2024-HK$0.94-92.59%
2023-HK$12.71160.89%
2022-HK$4.87-76.64%
2021-HK$20.8568.45%
2020-HK$12.38-68.91%
2019-HK$39.82-57.11%
2018-HK$92.84-272.22%
2017HK$53.91-199.29%
2016-HK$54.29798.7%
2015-HK$6.04-128.31%
2014HK$21.34-204.62%
2013-HK$20.40602.7%
2012-HK$2.90

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
-HK$1.49-91.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-HK$7.45-58.15%๐Ÿ‡บ๐Ÿ‡ธ USA